May 29, 2024 · Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease of the heart muscle. As it progresses, the heart can become unable to …

Mar 2, 2022 · Transthyretin cardiac amyloidosis (or ATTR-CM for short) is a heart condition that can lead to heart failure, and it can be fatal. Unfortunately, many of its symptoms are vague, …

Feb 19, 2025 · A big problem in ATTR-CM is the buildup of amyloid proteins in the heart. New treatments aim to remove these proteins, which could help your heart work better and ease …

Transthyretin amyloidosis (ATTR-CM) is a buildup of faulty proteins (fibrils) on your heart or nerves. It can cause cardiomyopathy and heart failure.

Jun 26, 2025 · ATTR-CM (transthyretin amyloid cardiomyopathy) is a rare condition that causes a range of vague symptoms, including shortness of breath. If left untreated, it can progress to …

ATTR-CM (transthyretin amyloid cardiomyopathy) is a serious condition where protein deposits accumulate in heart tissues, including valves, leading to progressive heart failure. This rare but …

Apr 8, 2025 · Transthyretin amyloid cardiomyopathy (ATTR-CM) is a type of heart disease that happens when an abnormal protein called amyloid builds up in the heart. Because the …

Jul 10, 2025 · What is ATTR-CM? Read on to learn more about this rare type of heart disease, including possible causes, different forms, symptoms, and treatments.

Explore the red flags of transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM), the signs and symptoms that should prompt additional assessments.

Mar 3, 2025 · Amyloidosis is more than a heart disease, and symptoms may affect different parts of the body, including the joints, leading to a more complex diagnosis. Understanding more …